Austria has lower cancer incidence and mortality rates compared to the EU average, with lung cancer being the leading cause of cancer death. The country faces challenges with risk factors such as smoking and alcohol consumption, which remain higher than the EU average. Overweight and obesity rates are rising, particularly among women with lower education levels. Austria has made progress in HPV vaccination but still ranks low in the EU. Early detection programs, particularly for breast and cervical cancer, show high self-reported rates but significant regional and educational disparities. The National Cancer Framework Programme emphasizes early detection, prevention, and quality of care. Cancer care in Austria is accessible but faces challenges with radiotherapy equipment supply and workforce shortages, particularly in rural areas. The country has high public reimbursement for cancer medicines and invests in advanced diagnostic equipment. Cancer care is expected to increase health spending and reduce life expectancy, but less than the EU average. Austria has comprehensive cancer care systems with vertically tiered structures and multidisciplinary tumour boards. The country is piloting electronic collection of patient-reported outcomes and integrating telemedicine and multidisciplinary care. While Austria has high five-year survival rates for most cancer types, potential years of life lost due to cancer are lower than the EU average. The country faces challenges in implementing the right to be forgotten for cancer survivors and lacks fertility preservation programs. Psycho-oncological interventions are available but access varies regionally. Austria provides substantial support for informal carers. Paediatric cancer incidence rates in Austria are higher than the EU average, but mortality rates are lower. The country has six institutions treating children with cancer and access to essential medicines and innovative therapies.
